MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze SKIN →
    • FindStock Picks / Stock Screener
    • Value · SKINIntrinsic Value Calculator
    • Invest · SKINInvestment Case
    • Hold · SKIN5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
SKIN stock logo

SKIN

SkinHealth Systems Inc.

$11.77
-0.38
 (-3.13%)
Exchange:  NASDAQ
Market Cap:  76.682M
Shares Outstanding:  6.319M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – SpecialtiesView industry performance
   
CEO:  Pedro Malha
Full Time Employees:  613
Address: 
3600 E. Burnett Street
Long Beach
CA
90815
US
Website:  https://www.skinhealthsystems.com
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Click to read more…

Revenue Segmentation

Revenue by type

Revenue by region

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
SKSKIN logoSKINSkinHealth Systems Inc.76.7M——2.1%
NYNYXH logoNYXHNyxoah S.A.82.0M——-68.1%
APAPYX logoAPYXApyx Medical Corporation101.1M——-6.4%
ANANIK logoANIKAnika Therapeutics, Inc.177.2M—11.9-0.4%
LALAB logoLABStandard BioTools Inc.249.1M——-6.6%
BWBWAY logoBWAYBrainsWay Ltd.332.6M34.729.29.3%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/08 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue397,991334,294300,790
Gross Profit155,113182,296196,364
EBITDA-53,56514,54238,737
Operating Income-130,917-67,774-20,803
Net Income-100,116-29,098-9,519

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets929,113685,683499,800
Total Liabilities869,723633,880438,700
Total Stockholders Equity59,39051,80361,100
Total Debt752,289568,158378,700
Cash and Cash Equivalents523,025370,063232,700

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow21,75016,13437,485
Capital Expenditure-13,049-6,794-5,163
Free Cash Flow8,7019,34032,322
Net Income-100,116-29,098-9,519
Net Change in Cash-45,172-152,962-137,390

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)323,909.397Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)332,859.956Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)328,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)37,406.211Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)37,668.438Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)37,526.022Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)5,744.672Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)5,951.832Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)5,839.323Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)237,216.409Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)243,771.389Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)240,212.180Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.860Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.880Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.850Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)2Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
334.294M  ?P/S
 (TTM)
: 
0.27
?Net Income
 (TTM)
: 
-29.098M  ?P/E
 (TTM)
: 
-4.13
?Enterprise Value
 (TTM)
: 
228.535M  ?EV/FCF
 (TTM)
: 
12.49
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
-32.09%  ?ROIC
 (TTM)
: 
2.14%
?Net Debt
 (TTM)
: 
198.095M  ?Debt/Equity
 (TTM)
: 
4.74
?P/B
 (TTM)
: 
1.37  ?Current Ratio
 (TTM)
: 
2.89

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates SKIN intrinsic value between $20.32 – $27.00 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate SKIN Intrinsic Value

Common questions about SKIN valuation

Is SkinHealth Systems Inc. (SKIN) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for SkinHealth Systems Inc. (SKIN) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SKIN a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SKIN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is SKIN’s P/E ratio?

You can see SKIN’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for SKIN?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is SKIN a good long-term investment?

Whether SKIN fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for SkinHealth Systems Inc.

  • SkinHealth Systems Inc. intrinsic value calculatorEstimate what the business is worth
  • SkinHealth Systems Inc. 5-year outlookWhat has to go right, and what could go wrong
SKIN

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-3.13
MarketSnap

Trading Metrics:

Open: 12.02   Previous Close: 12.15
Day Low: 11.76   Day High: 12.2
Year Low: 9.68   Year High: 33
Price Avg 50: 12.5   Price Avg 200: 15.58
Volume: 88470   Average Volume: 119508

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

Investing in SkinHealth Systems Inc. (SKIN)? Don't Miss Assessing Its International Revenue Trends
09-11-2026 10:16
Investing in SkinHealth Systems Inc. (SKIN)? Don't Miss Assessing Its International Revenue Trends
Beauty Health Q3 Earnings Call Highlights
06-11-2026 13:16
Beauty Health Q3 Earnings Call Highlights
SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026
22-10-2026 10:00
SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026
SkinHealth Systems Inc. (SKIN) Soars 9.0%: Is Further Upside Left in the Stock?
16-10-2026 05:16
SkinHealth Systems Inc. (SKIN) Soars 9.0%: Is Further Upside Left in the Stock?
SkinHealth Systems Announces Reverse Stock Split
09-10-2026 09:00
SkinHealth Systems Announces Reverse Stock Split
e.l.f. SKIN's Save Your e.l.f. Hypochlorous Mist Helps Soothe Stress in every e.l.f.ing mist-mergency
09-10-2026 00:01
e.l.f. SKIN's Save Your e.l.f. Hypochlorous Mist Helps Soothe Stress in every e.l.f.ing mist-mergency

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze SKIN →
    • FindStock Picks / Stock Screener
    • Value · SKINIntrinsic Value Calculator
    • Invest · SKINInvestment Case
    • Hold · SKIN5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.